Enroll in Our Diabetes Study!

First Study (California Only)

Allied Clinical staff encourages those who suffer from Type 2 Diabetes who are currently prescribed METFORMIN to consider enrolling in our clinical study. 

highbloodsugarsymptoms

Click here for more information on diabetes

This study will evaluate the effectiveness of reducing blood sugar levels and A1C (a blood test that measures how well your blood glucose is controlled over time) by adding either the investigational medication sotagliflozin, commercially available glimepiride, or placebo to currently prescribed doses of metformin in patients with Type 2 Diabetes.  Sotagliflozin is an SGLT1/SGLT2 inhibitor that works in the kidneys to allow more sugar to be lost in your urine and also reduces the amount of sugar that is absorbed in your intestine thereby potentially assisting in lowering blood sugar.  During this year-long study, you will be required to visit the clinic once per month on average and are allowed to continue your current dose of metformin for diabetic treatment.

Insurance is not required to participate, and study medications related to Type 2 Diabetes will be provided at no charge.  In addition patients will receive free glucose meters and test strips, medical evaluations, procedures, and diagnostic testing.  Compensation will be provided to those that qualify at $50 for each completed visit, up to a maximum of $600 for the duration of the entire study.

In order to qualify for the study, patients must meet the following requirements:

  • Be 18 years of age or older
  • Have been diagnosed with Type 2 diabetes and prescribed Metformin/Glucophage by a physician
  • Are able to complete diabetic finger tests on most days and log results in a diary
  • Cannot be taking another diabetes medication or diagnosed with Type 1 diabetes
  • Have a body mass index (BMI) of 20 – 45
  • Cannot have hepatitis or other liver disease
  • Have not had gastric surgery in the past year (bypass, banding, etc)
  • Have abused drugs or alcohol in the past 6 months
  • Cannot have uncontrolled high blood pressure
  • Are not pregnant or breastfeeding

 

Second Study (California Only)

Allied Clinical staff encourages those who suffer from Type 2 Diabetes who may have moderate kidney impairment to consider enrolling in our clinical study. 

This study will evaluate the effectiveness of the investigational medication sotagliflozin to reduce blood sugar levels and A1C (a blood test that measures how well your blood glucose is controlled over time) better than a placebo in patients with Type 2 Diabetes and moderate kidney problems. Sotagliflozin is an SGLT1/SGLT2 inhibitor that works in the kidneys to allow more sugar to be lost in your urine and also reduces the amount of sugar that is absorbed in your intestine thereby potentially assisting in lowering blood sugar.  During the year-long study, patients will be required to visit the clinic once per month on average and are allowed to continue their current diabetic treatment.

Insurance is not required to participate, and study related medications to treat Type 2 Diabetes will be provided at no charge.  In addition patients will receive free glucose meters and test strips, medical evaluations, procedures, and diagnostic testing. Compensation will be provided to those that qualify at $50 for each visit you complete, up to a maximum of $600 for the duration of the study.

In order to qualify for the study, patients must meet the following requirements:

  • Be 18 years of age or older
  • Been diagnosed with Type 2 diabetes and have kidney issues (blood test)
  • Have a body mass index (BMI) of 20 – 45
  • Must be willing to complete diabetic finger testing on most days and log results in a diary for review
  • Cannot be diagnosed with Type 1 diabetes
  • Have not had gastric surgery in the past year (bypass, banding, etc)
  • Do not require treatment for hepatitis or other liver disease
  • Have abused drugs or alcohol in the past 6 months
  • Cannot be on dialysis or have uncontrolled high blood pressure
  • Are not pregnant or breastfeeding